[Imeglimin: features of the mechanism of action and potential benefits]. [PDF]
Probl Endokrinol (Mosk), 2022 Kuznetsov KO +7 more
europepmc +1 more source
[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof]. [PDF]
Probl Endokrinol (Mosk)Cheplyaeva NI +4 more
europepmc +1 more source
[Time-restricted eating as a novel strategy for treatment of obesity and it's comorbid conditions]. [PDF]
Probl Endokrinol (Mosk), 2022 Berkovskaya MA +3 more
europepmc +1 more source
[Evolution of insulin therapy: past, present, future]. [PDF]
Probl Endokrinol (Mosk)Kurkin DV +13 more
europepmc +1 more source
[Characteristics of purchases of hypoglycemic agents in pharmacy retail sector in 2016-2020 years dynamics]. [PDF]
Probl Endokrinol (Mosk), 2023 Kurkin DV +7 more
europepmc +1 more source
[Polycystic ovary syndrome: new and promising treatment methods]. [PDF]
Probl Endokrinol (Mosk)Gasieva DM +4 more
europepmc +1 more source
[Adipsic diabetes insipidus after transsphenoidal surgery for suprasellar intraventricular]. [PDF]
Probl Endokrinol (Mosk), 2022 Astafyeva LI +6 more
europepmc +1 more source
[Cognitive impairment in patients with obesity and impaired carbohydrate metabolism (dysglycemia)]. [PDF]
Probl Endokrinol (Mosk)Dzgoeva FK, Ekusheva EV, Demidova VV.
europepmc +1 more source
[Electroencephalogram features in children with congenital hyperinsulinism treated according to the international protocol in Russian Federation]. [PDF]
Probl Endokrinol (Mosk), 2023 Sarakaeva LR +8 more
europepmc +1 more source